Patentee doublethink in regulatory submissions and patent prosecution is inequitable conduct: Belcher v. Hospira (US)
The US Courts of Appeal of the Federal Circuit (CAFC) found in Belcher Pharmaceuticals v Hospira, Inc that a formulation patent was unenfo...
Dr Rose Hughes -
Thursday, September 23, 2021
Patentee doublethink in regulatory submissions and patent prosecution is inequitable conduct: Belcher v. Hospira (US)
Reviewed by Dr Rose Hughes
on
Thursday, September 23, 2021
Rating:
Reviewed by Dr Rose Hughes
on
Thursday, September 23, 2021
Rating: